MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Inflammation"

  • 2025 International Congress

    Spectrum of Movement Disorders Associated With Autoimmune Thyroid Disease

    A. Maheshwary, S. Anderson, N. Prakash (Farmington, USA)

    Objective: To describe the spectrum of movement disorders in patients with positive anti-thyroid antibodies (ATA+). Background: Autoimmune thyroid diseases (AITD), including Hashimoto’s thyroiditis (HT) and…
  • 2025 International Congress

    Distinct Peripheral Immune Profiles of Parkinson’s Disease and Multiple System Atrophy

    S. Jo, I. Jang, J. Lee, M. Choi, E. Lee, SJ. Chung (Seoul, Republic of Korea)

    Objective: We aimed to compare peripheral blood mononuclear cell (PBMC) subsets between Parkinson’s disease (PD) and multiple system atrophy (MSA) to identify disease-specific immune signatures…
  • 2025 International Congress

    Chronic Exercise and Systemic Inflammation in Parkinson’s Disease: Exploring the Role of Exercise Modality

    J. Cristini, F. Seo, A. Bon, A. Potvin-Desrochers, J. Mustafa, A. Dagher, R. Postuma, P. Rosa-Neto, J. Carrier, A. Amara, S. Steib, C. Paquette, M. Roig (Montreal, Canada)

    Objective: To investigate the effects of 12 weeks of cardiovascular, resistance, multimodal training, or a waiting list condition on the concentrations of inflammatory blood markers…
  • 2025 International Congress

    Therapeutic Efficacy of Human Dental Pulp Stem Cells-Derived Exosome-Encased Phloroglucinol In MPTP-Induced Chronic Parkinsonian Rat model: Potential for Disease Modification

    I. Datta, K. Mondal, R. Ghanty, G. Wagmare, A. Mahadevan, R. Santhoshkumar, N. Bn (Bengaluru, India)

    Objective: This study aimed to evaluate the therapeutic efficacy of intranasally administered exosome-encased phloroglucinol (Exo-Phl) in a MPTP rat model of PD. Background: Dopaminergic (DA)…
  • 2025 International Congress

    Salivary Biomarkers in Parkinson’s Disease: A Follow-Up Study

    MI. de Bartolo, D. Belvisi, E. Patricolo, M. Costanzo, C. Cutrona, F. Aiello, G. Leodori, A. Conte, G. Fabbrini, A. Berardelli, G. Vivacqua (Rome, Italy)

    Objective: Investigate longitudinal changes in salivary levels of oligomeric and total a-synuclein (a-syn), phosphorylated-tau (p-tau), total tau, MAP-LC3, and TNFa in Parkinson’s Disease (PD) patientsAssess…
  • 2025 International Congress

    Gut Dysbiosis Alters Host Metabolism but Does Not Independently Induce Parkinson’s Disease Pathology

    HY. Huang, TH. Yeh, SP. Tsao (Taipei, Taiwan)

    Objective: To determine whether gut dysbiosis alone is sufficient to induce Parkinson’s disease (PD) pathology and to investigate its impact on host metabolism. Background: Gut…
  • 2025 International Congress

    Alpha-Synuclein Preformed Fibrils Increase the Frequency of CXCR3+ B-cells in Early-stage Parkinson’s Disease Patients

    H. Hong, M. Dean, D. Standaert, H. Qin, E. Benveniste (Birmingham, USA)

    Objective: To investigate the effect of a-Syn Preformed Fibrils (PFF) on CXCR3 expression on B-cells in Parkinson’s Disease (PD) patients at early (E-PD, diagnosed less…
  • 2025 International Congress

    Hyperbaric Oxygen Therapy for Parkinson’s disease via modulation of gut microbiota

    V. Vedam-Mai, J. Long, N. Nair, D. Fuller, K. Deegan, S. Rana, G. Iglesias, I. Gonzalez, U. Dissanayake, V. Mai (Gainesville, USA)

    Objective: To investigate the effect of hyperbaric oxygen therapy (HBOT) on gut microbiota in a preclinical model of PD. Background: Humans have coevolved with complex…
  • 2025 International Congress

    Immune cell changes in early Dementia with Lewy Bodies

    T. Yacoubian, H. Qin, A. Amara, N. Stover, L. Ruffrage, M. Dean, Y. Zhang, R. Kennedy, D. Geldmacher, A. Gerstenecker, D. Standaert, E. Benveniste (AURORA, USA)

    Objective: To examine if immune cell changes are present in early stages of Dementia with Lewy Bodies (DLB). Background: Evidence for inflammation in synucleinopathies has…
  • 2025 International Congress

    Paeoniflorin Combined with Neural Stem Cell Transplantation for Parkinson’s Disease: Synergistic Effects of Cell Therapy and Inflammation Regulation

    SJ. Peng, LP. Wang, YJ. Ou, RE. Liu (Beijing, China)

    Objective: To investigate the feasibility and efficacy of paeoniflorin (PF) combined with neural stem cell (NSC) transplantation in treating Parkinson's disease (PD). Background: Parkinson's disease…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 28
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley